Other terms
- Immunotherapy
- Inclusion/Exclusion criteria
- IND-Enabling Trial
- Inflammatory Bowel Disease (IBD)
- Inflammatory Myopathies
- Informed Consent
- Informed Consent Form
- Institutional Review Board (IRB)/Independent Ethics Committee (IEC)
- Investigational New Drug Application
- Investigational New Drug Application (IND)
- IRT (Interactive Response technology)
- itRECIST
Immuno-oncology
What is Immune-oncology? Immuno-oncology comprises immunotherapy methods used to augment the function of the patient’s immune system to prevent the spread of cancer by recognizing and eradicating tumor cells.
What are the Types of Immuno-oncology?
The choice of immune-oncology treatment depends upon the cancer and the patient’s condition and medical history. There are several types of immunotherapy available for cancer treatment:
- Immune checkpoint inhibitors
- Adoptive cell therapies
- Monoclonal antibodies
- Treatment vaccines
- Oncolytic virus therapy
- Immune system modulators
Common Side Effects of Immuno-oncology
Side effects depend on the drug being used and the mechanism of action. Some commonly experienced side effects can include:
- Rashes
- Pruritis
- Flu-like symptoms
- Diarrhea
Source: Jain, K. K. (2020, August 25). Personalized Immuno-Oncology. Medical Principles and Practice, 30(1), 1–16. https://doi.org/10.1159/000511107
